Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Sarcoma
What dose-fractionation and clinical target volume do you use when treating tenosynovial giant cell tumor (TGCT), historically known as pigmented villonodular synovitis (PVNS), of the knee?
Answer from: Radiation Oncologist at Community Practice
4500 cGy at 180cGy/fx.
Sign In
or
Register
to read more
14297
Related Questions
In a patient with an R1 resection of a chordoma who has declined proton therapy, what alternative radiation modality would you recommend?
How would you approach adjuvant treatment in a patient with completely resected undifferentiated pleomorphic sarcoma of the chest wall that recurred after 2 years, initially treated with neoadjuvant radiation and resection?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
Is it appropriate to use electrons to treat a fibrosarcomatous DFSP of the face s/p R1 WLE?
How would you treat a primary angiosarcoma arising in the skull, excised with initial excisional biopsy?
Would you recommend adjuvant radiation for a large dedifferentiated anterior abdominal wall liposarcoma?
How do you consider SBRT relative to other emerging therapies for pediatric sarcomas, such as proton therapy or immunotherapy, in terms of efficacy and safety?
How would you treat an unresectable epithelioid angiosarcoma invading the cavernous sinus, wrapping around the carotid artery?
What is the recommended approach for a 7 cm x 5 cm paraspinal subcutaneous desmoid tumor (T6 to T9) incidentally detected on PET CT during NSCLC monitoring, with confirmed growth over 18 months?
How would you manage an epidural spinal metastasis causing cord compression from rhabdomyosarcoma?